• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: RAKIN KEVIN was granted 1,921,512 units of Class A Common Stock

    6/15/21 5:27:21 PM ET
    $CAPA
    Business Services
    Finance
    Get the next $CAPA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    RAKIN KEVIN

    (Last) (First) (Middle)
    C/O QUANTUM-SI INCORPORATED
    530 OLD WHITFIELD STREET

    (Street)
    GUILFORD CT 06437

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Quantum-Si Inc [ QSI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/10/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 06/10/2021 A 1,901,000(1)(2)(3) A $10 1,901,000 I See Footnote(1)
    Class A Common Stock 06/11/2021 A 20,512(4) A $0.00 20,512 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Consists of (i) 100,000 shares of the Company's Class A common stock held by Mr. Rakin and the Kevin L. Rakin Irrevocable Trust, (ii) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (iii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and
    2. (iv) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
    3. In connection with the closing of the transactions (the "Business Combination") contemplated by the Business Combination Agreement, dated as of February 18, 2021, by and among HighCape Capital Acquisition Corp. ("HighCape"), Tenet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HighCape ("Merger Sub"), and Quantum-Si Incorporated, a Delaware corporation ("Quantum-Si"), pursuant to which Merger Sub merged with and into Quantum-Si (the "Merger"), with Quantum-Si surviving as a wholly-owned subsidiary of HighCape (which changed its name to "Quantum-Si Incorporated", the "Issuer"), these shares were purchased, at a price of $10.00 per share, in a private placement immediately prior to the closing of the Merger.
    4. Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on June 11, 2022, subject to Mr. Rakin's continued service through the applicable vesting date.
    /s/ Kevin Rakin 06/15/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CAPA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAPA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CAPA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Issuer Direct Announces New Board of Directors to Support Next Chapter of Growth

      RALEIGH, NC / ACCESSWIRE / July 1, 2024 / Issuer Direct Corporation (NYSE:ISDR), an industry-leading communications company, today announced it has appointed Wes Pollard and Joe Staples as new independent members of its Board of Directors."We are excited to welcome Wes and Joe to the Issuer Direct Board of Directors," said CEO Brian Balbirnie. "We believe their respective skillsets are an ideal fit for us as we pursue our strategic vision to be a leading provider of media and communications software to the PR (Public Relations) and IR (Investor Relations) industry. We are confident they will be valuable additions to our company as we continue to optimize our business and work to maximize val

      7/1/24 10:45:00 AM ET
      $ISDR
      $CAPA
      Publishing
      Consumer Discretionary
      Business Services
      Finance
    • Quantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing Platform

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing system to key opinion leaders across the globe, for both expansion and development of applications and workflows. "The Company is experiencing tremendous momentum and demand for participation in our early access program to analyze previously unapproachable levels of biological understanding of t

      10/19/21 4:15:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 27-30, 2021. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, September 29, at 1:20 – 1:50 pm EDT. Please visit the Investor Relations section of the Quantum-Si website here to view the Company's most recent corporate presentation. About Quantum-Si Incorporated Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focus

      9/21/21 4:15:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials

    $CAPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: RAKIN KEVIN was granted 1,921,512 units of Class A Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/15/21 5:27:21 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form 4: ROTHBERG JONATHAN M was granted 17,213,479 units of Class A Common Stock and was granted 19,937,500 units of Class B Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/14/21 6:56:10 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form 4: Makes Brigid was granted 20,512 units of Class A Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/14/21 6:56:44 PM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    Leadership Updates

    Live Leadership Updates

    See more
    • Quantum-Si Strengthens Board of Directors With Two Key Appointments

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition Corp (NASDAQ:CAPA). "We are positioning Quantum-Si to have the best chance of delivering on the promise of next-generation proteomics by continuing to enhance our leadership team and board of directors, including the addition of Dr. Marijn Dekkers, former

      5/6/21 8:00:00 AM ET
      $CAPA
      Business Services
      Finance
    • Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Michael Mina, M.D., Ph.D., Assistant Professor of Epidemiology, Immunology, Infectious Diseases and Pathology at the Harvard T.H. Chan School of Public Health and Harvard Medical School, as Chief Medical Advisor for the company. "As we create the next generation of protein sequencing and proteomics to transform how we study and diagnose disease, moving from the analog to the digital world and allowing a level of sensitivity, precision and understanding never before possible, Dr. Mina's expertise will be invaluable in guiding Quantum-Si's application efforts,

      4/29/21 8:00:00 AM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    Financials

    Live finance-specific insights

    See more
    • Quantum-Si Reports Second Quarter 2021 Financial Results

      Quantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced financial results for the quarter ended June 30, 2021 and provided a business update. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Quantum-Si's Chief Financial Officer, will host a call today at 4:30 pm EDT to review the Company's results. Recent Highlights: Completed the business combination with HighCape Capital Acquisition Corp. ("HighCape"), adding over $511 million in cash to the balance sheet. Successfull

      8/16/21 4:05:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET on August 16, 2021, to discuss second quarter 2021 financial results and provide a business update. The conference call will be broadcast live in listen-only mode via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. Individuals interested in listening to the conference call on y

      8/11/21 7:00:00 AM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials

    $CAPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by HighCape Capital Acquisition Corp.

      SC 13D - Quantum-Si Inc (0001816431) (Subject)

      6/21/21 5:20:40 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form SC 13D filed by HighCape Capital Acquisition Corp.

      SC 13D - Quantum-Si Inc (0001816431) (Subject)

      6/21/21 3:37:21 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form SC 13D/A filed by HighCape Capital Acquisition Corp. (Amendment)

      SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

      6/14/21 5:18:16 PM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    SEC Filings

    See more
    • HighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update

      8-K - Quantum-Si Inc (0001816431) (Filer)

      7/6/21 6:52:38 AM ET
      $CAPA
      Business Services
      Finance
    • SEC Form S-1 filed by HighCape Capital Acquisition Corp.

      S-1 - Quantum-Si Inc (0001816431) (Filer)

      7/2/21 5:00:18 PM ET
      $CAPA
      Business Services
      Finance
    • HighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update

      8-K - Quantum-Si Inc (0001816431) (Filer)

      6/25/21 4:37:54 PM ET
      $CAPA
      Business Services
      Finance